Simplex Trading
TXG icon

Simplex Trading’s 10x Genomics TXG Stock Holding History

Simplex Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
6,800
+6,700
+6,700% +$176K ﹤0.01% 4390
2026
Q1 		$2.12K Sell
100
-31,800
-100% -$636K ﹤0.01% 8353
2025
Q4 		$520K Sell
31,900
-34,600
-52% -$523K ﹤0.01% 3268
2025
Q3 		$777K Buy
66,500
+100
+0.2% +$1.3K ﹤0.01% 3311
2025
Q2 		$768K Buy
66,400
+62,600
+1,647% +$571K ﹤0.01% 3063
2025
Q1 		$33K Sell
3,800
-2,500
-40% -$31.5K ﹤0.01% 6174
2024
Q4 		$90K Buy
6,300
+2,300
+58% +$36.3K ﹤0.01% 5281
2024
Q3 		$90K Buy
4,000
+900
+29% +$18.6K ﹤0.01% 5345
2024
Q2 		$60K Sell
3,100
-5,800
-65% -$152K ﹤0.01% 5897
2024
Q1 		$334K Sell
8,900
-6,500
-42% -$286K ﹤0.01% 4271
2023
Q4 		$861K Sell
15,400
-4,800
-24% -$209K ﹤0.01% 3147
2023
Q3 		$833K Sell
20,200
-8,900
-31% -$463K ﹤0.01% 2864
2023
Q2 		$1.62M Buy
29,100
+18,100
+165% +$980K ﹤0.01% 2146
2023
Q1 		$613K Buy
11,000
+10,700
+3,567% +$500K ﹤0.01% 3064
2022
Q4 		$10K Sell
300
-18,100
-98% -$592K ﹤0.01% 7581
2022
Q3 		$524K Sell
18,400
-6,000
-25% -$229K ﹤0.01% 3413
2022
Q2 		$1.1M Buy
24,400
+15,600
+177% +$809K ﹤0.01% 2507
2022
Q1 		$669K Buy
+8,800
New +$770K ﹤0.01% 3445
2021
Q4 		– Sell
-700
Closed -$132K – 11469
2021
Q3 		$132K Hold
700
– – ﹤0.01% 6232
2021
Q2 		$137K Buy
700
+696
+17,400% +$126K ﹤0.01% 6274
2021
Q1 		$72K Sell
4
-93
-96% -$16.1K ﹤0.01% 6175
2020
Q4 		$1.37M Buy
97
+48
+98% +$6.96K ﹤0.01% 2164
2020
Q3 		$610K Buy
49
+34
+227% +$3.57K ﹤0.01% 2771
2020
Q2 		$133K Sell
15
-6
-29% -$467 ﹤0.01% 4485
2020
Q1 		$130K Sell
21
-22
-51% -$1.72K ﹤0.01% 4091
2019
Q4 		$327K Buy
+43
New +$2.58K ﹤0.01% 3184

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading's TXG Position: Q2 2026 in Review

Simplex Trading opened a new position in 10x Genomics (TXG) in Q2 2026: 51,807 shares worth $1.99M. The stake represents ﹤0.01% of the portfolio and ranks #2049 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TXG as recently as Q4 2025.

Simplex Trading first reported a position in TXG in Q4 2019 and has held it in 13 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Simplex Trading held 51,807 shares of 10x Genomics worth $1.99M as of Q2 2026.
  • 10x Genomics was a new Simplex Trading position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2049 holding.
  • Simplex Trading first reported a position in 10x Genomics in Q4 2019 and has held it in 13 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.